BARCLAYS PLC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$34,000
-93.7%
26,470
-93.8%
0.00%
Q4 2021$542,000
+86.9%
425,970
+220.4%
0.00%
Q3 2021$290,000
-55.6%
132,954
-23.8%
0.00%
Q2 2021$653,000
-1.8%
174,379
-14.6%
0.00%
Q1 2021$665,000
-11.3%
204,073
-7.2%
0.00%
Q4 2020$750,000
-28.4%
219,893
-14.4%
0.00%
-100.0%
Q3 2020$1,048,000
+70.7%
256,965
+41.6%
0.00%
Q2 2020$614,000
+126.6%
181,496
+55.8%
0.00%
Q1 2020$271,000
-61.8%
116,484
-40.3%
0.00%
Q4 2019$710,000
-66.0%
195,165
-22.3%
0.00%
-100.0%
Q3 2019$2,086,000
-40.9%
251,311
-38.7%
0.00%
-50.0%
Q2 2019$3,531,000
+189.2%
410,018
+259.0%
0.00%
+100.0%
Q1 2019$1,221,000
+105.2%
114,216
+67.7%
0.00%
Q4 2018$595,000
-87.5%
68,124
-75.9%
0.00%
-100.0%
Q3 2018$4,747,000
+64.5%
282,615
+105.3%
0.00%
+50.0%
Q2 2018$2,885,000
-83.6%
137,648
-87.4%
0.00%
-84.6%
Q1 2018$17,539,000
-15.8%
1,090,141
-0.9%
0.01%
-23.5%
Q4 2017$20,838,000
+36.2%
1,099,645
+1.2%
0.02%
+6.2%
Q3 2017$15,294,000
+99.7%
1,087,033
+5.8%
0.02%
+100.0%
Q2 2017$7,657,000
+15.7%
1,027,875
+1.0%
0.01%
+14.3%
Q1 2017$6,617,000
+48.2%
1,018,037
+1.0%
0.01%
+40.0%
Q4 2016$4,464,000
-6.5%
1,007,966
-1.4%
0.01%0.0%
Q3 2016$4,772,000
-29.4%
1,022,295
-0.6%
0.01%
-44.4%
Q2 2016$6,756,000
+12.9%
1,028,384
+3.1%
0.01%0.0%
Q1 2016$5,984,000
+0.3%
997,209
+0.3%
0.01%
+28.6%
Q4 2015$5,968,000
+10.4%
994,602
-8.0%
0.01%
+16.7%
Q3 2015$5,405,000
-11.0%
1,081,110
+6.9%
0.01%
-14.3%
Q2 2015$6,070,000
-3.4%
1,011,592
-3.3%
0.01%0.0%
Q1 2015$6,281,000
-1.6%
1,046,486
-1.7%
0.01%
+16.7%
Q4 2014$6,386,000
-25.7%
1,064,244
-1.0%
0.01%
-25.0%
Q3 2014$8,597,000
+1.4%
1,074,642
+1.4%
0.01%
-11.1%
Q2 2014$8,479,000
+11.6%
1,060,000
-2.3%
0.01%
+12.5%
Q1 2014$7,595,000
-10.6%
1,085,102
+2.2%
0.01%0.0%
Q4 2013$8,495,000
-4.6%
1,062,032
-4.6%
0.01%
-20.0%
Q3 2013$8,901,000
+1.3%
1,112,715
-5.5%
0.01%
-9.1%
Q2 2013$8,785,0001,177,6710.01%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders